HEALTH● LOWAug 14 · Aug 14, 2026, 12:31 PM
Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s
Seeking Alpha Tech
Lantheus has received approval from the FDA for its tau PET imaging agent, intended for use in Alzheimer's disease. This approval marks a significant development in medical diagnostics for Alzheimer's.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoAgostina Hein withdrew from the South American Games due to her recovery after an appendicitis operationClarínHEALTH1h agoCourt records indicate insanity defense for woman charged in Hoffman deathkctv5.com · United StatesHEALTH1h agoT - Boz Steps Back From Tour to Focus on Her Healththeroot.com · United StatesHEALTH1h agoUnion de Reyes Faces Surge in Fever Cases Amid Arbovirus Spread and Fumigation Challengescubaheadlines.com · Cuba